These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


381 related items for PubMed ID: 17121717

  • 1. [Cytotoxic effect of oncolytic virus combined with mitomycin against human bladder cancer cells in vitro and in vivo].
    Zhao GZ, Tan WL, Zheng SB, Wu YD, Xie Y, Zhu WH.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1623-5, 1628. PubMed ID: 17121717
    [Abstract] [Full Text] [Related]

  • 2. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.
    Hadaschik BA, Adomat H, Fazli L, Fradet Y, Andersen RJ, Gleave ME, So AI.
    Clin Cancer Res; 2008 Mar 01; 14(5):1510-8. PubMed ID: 18316576
    [Abstract] [Full Text] [Related]

  • 3. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB, Wu CT, Wang H, Zhang QW, Wang L, Wang RL, Lu ZZ, Wang LS.
    Cancer Gene Ther; 2008 Mar 01; 15(3):173-82. PubMed ID: 18157145
    [Abstract] [Full Text] [Related]

  • 4. An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer.
    Zhong S, Yu D, Wang Y, Qiu S, Wu S, Liu XY.
    Acta Oncol; 2010 Mar 01; 49(1):91-9. PubMed ID: 19734998
    [Abstract] [Full Text] [Related]

  • 5. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
    Liu C, Sarkaria JN, Petell CA, Paraskevakou G, Zollman PJ, Schroeder M, Carlson B, Decker PA, Wu W, James CD, Russell SJ, Galanis E.
    Clin Cancer Res; 2007 Dec 01; 13(23):7155-65. PubMed ID: 18056196
    [Abstract] [Full Text] [Related]

  • 6. Tumor-selective replication of an oncolytic adenovirus carrying oct-3/4 response elements in murine metastatic bladder cancer models.
    Wu CL, Shieh GS, Chang CC, Yo YT, Su CH, Chang MY, Huang YH, Wu P, Shiau AL.
    Clin Cancer Res; 2008 Feb 15; 14(4):1228-38. PubMed ID: 18281558
    [Abstract] [Full Text] [Related]

  • 7. Antitumor effects of two newly constructed oncolytic herpes simplex viruses against renal cell carcinoma.
    Fu X, Nakamori M, Tao L, Amato R, Zhang X.
    Int J Oncol; 2007 Jun 15; 30(6):1561-7. PubMed ID: 17487379
    [Abstract] [Full Text] [Related]

  • 8. [Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy].
    Shi M, Yao L, Wang FS, Lei ZY, Zhang B, Li WL, Liu JC, Tang ZR, Zhou GD.
    Zhonghua Zhong Liu Za Zhi; 2004 Aug 15; 26(8):465-8. PubMed ID: 15555334
    [Abstract] [Full Text] [Related]

  • 9. Potent oncolytic activity of human enteroviruses against human prostate cancer.
    Berry LJ, Au GG, Barry RD, Shafren DR.
    Prostate; 2008 May 01; 68(6):577-87. PubMed ID: 18288643
    [Abstract] [Full Text] [Related]

  • 10. Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma.
    Boozari B, Mundt B, Woller N, Strüver N, Gürlevik E, Schache P, Kloos A, Knocke S, Manns MP, Wirth TC, Kubicka S, Kühnel F.
    Gut; 2010 Oct 01; 59(10):1416-26. PubMed ID: 20675696
    [Abstract] [Full Text] [Related]

  • 11. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
    Jarnagin WR, Zager JS, Hezel M, Stanziale SF, Adusumilli PS, Gonen M, Ebright MI, Culliford A, Gusani NJ, Fong Y.
    Cancer Gene Ther; 2006 Mar 01; 13(3):326-34. PubMed ID: 16138120
    [Abstract] [Full Text] [Related]

  • 12. Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus.
    Diaconu I, Cerullo V, Hirvinen ML, Escutenaire S, Ugolini M, Pesonen SK, Bramante S, Parviainen S, Kanerva A, Loskog AS, Eliopoulos AG, Pesonen S, Hemminki A.
    Cancer Res; 2012 May 01; 72(9):2327-38. PubMed ID: 22396493
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of antitumor activity of herpes simplex virus gamma(1)34.5-deficient mutant for oral squamous cell carcinoma cells by hexamethylene bisacetamide.
    Naito S, Obayashi S, Sumi T, Iwai S, Nakazawa M, Ikuta K, Yura Y.
    Cancer Gene Ther; 2006 Aug 01; 13(8):780-91. PubMed ID: 16645620
    [Abstract] [Full Text] [Related]

  • 14. Induction of strong antitumor immunity by an HSV-2-based oncolytic virus in a murine mammary tumor model.
    Li H, Dutuor A, Fu X, Zhang X.
    J Gene Med; 2007 Mar 01; 9(3):161-9. PubMed ID: 17266169
    [Abstract] [Full Text] [Related]

  • 15. Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models.
    Ganesh S, Gonzalez-Edick M, Gibbons D, Van Roey M, Jooss K.
    Clin Cancer Res; 2008 Jun 15; 14(12):3933-41. PubMed ID: 18559615
    [Abstract] [Full Text] [Related]

  • 16. Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil.
    Chu L, Gu J, Sun L, Qian Q, Qian C, Liu X.
    Gene Ther; 2008 Apr 15; 15(7):484-94. PubMed ID: 18239605
    [Abstract] [Full Text] [Related]

  • 17. Oncolytic herpes simplex virus treatment of metastatic breast cancer.
    Wang J, Hu P, Zeng M, Rabkin SD, Liu R.
    Int J Oncol; 2012 Mar 15; 40(3):757-63. PubMed ID: 22108767
    [Abstract] [Full Text] [Related]

  • 18. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
    Hadaschik BA, Zhang K, So AI, Fazli L, Jia W, Bell JC, Gleave ME, Rennie PS.
    Cancer Res; 2008 Jun 15; 68(12):4506-10. PubMed ID: 18559493
    [Abstract] [Full Text] [Related]

  • 19. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.
    Gentschev I, Stritzker J, Hofmann E, Weibel S, Yu YA, Chen N, Zhang Q, Bullerdiek J, Nolte I, Szalay AA.
    Cancer Gene Ther; 2009 Apr 15; 16(4):320-8. PubMed ID: 18949014
    [Abstract] [Full Text] [Related]

  • 20. Enhanced sensitivity to mitomycin C by abating heat shock protein 70 expression in human bladder cancer cell line of BIU-87.
    He LF, Guan KP, Yan Z, Ye HY, Xu KX, Ren L, Hou SK.
    Chin Med J (Engl); 2005 Dec 05; 118(23):1965-72. PubMed ID: 16336832
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.